+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
AI Medical Imaging Software for Cardiovascular Disease Market - Global Forecast 2026-2032- Product Image
AI Medical Imaging Software for Cardiovascular Disease Market - Global Forecast 2026-2032- Product Image
New

AI Medical Imaging Software for Cardiovascular Disease Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 188 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6125578
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

AI medical imaging software for cardiovascular disease is rapidly becoming integral to modern healthcare systems, offering streamlined diagnostics and supporting more precise, dependable outcomes across diverse care environments.

Market Snapshot: AI Medical Imaging Software for Cardiovascular Disease

The market for AI medical imaging software dedicated to cardiovascular disease is experiencing sustained growth, climbing from USD 2.40 billion in 2025 to USD 2.56 billion in 2026. Looking ahead, the market is projected to reach USD 4.94 billion by 2032, supported by a robust CAGR of 10.85%. This expansion is driven by the increasing adoption of AI to address a surge in imaging volumes, wide-ranging workforce shortages, and the pressing need for consistent, standardized diagnostic quality across hospital networks and cardiology clinics. Healthcare leaders prioritize AI-enabled solutions that enhance operational efficiency and respond to expanding patient needs across multi-site organizations.

Scope & Segmentation

This comprehensive report analyzes the evolving landscape of AI medical imaging for cardiovascular disease, providing actionable insights across several essential segments relevant to providers, technology vendors, and investors.

  • Offering Type: Covers software-only AI solutions and integrated platforms that include workflow orchestration, analytics, and governance to deliver broad operational value.
  • Imaging Modality: Encompasses echocardiography, cardiac CT, MRI, nuclear cardiology, and angiography to support varied clinical imaging requirements.
  • Clinical Application: Encompasses tools for screening, triage, quantitative analysis, disease progression tracking, and decision support linked directly to care pathways.
  • End User: Addresses the needs of hospitals, diagnostic imaging centers, and specialized cardiology practices, spanning high-volume healthcare environments to focused specialty providers.
  • Deployment Model: Assesses cloud, on-premises, and hybrid implementations, each tailored to IT infrastructure, data residency, and performance standards.
  • Geographical Regions: Features in-depth analysis covering the Americas, Europe, Middle East & Africa, and Asia-Pacific, acknowledging regional regulatory, clinical, and operational differences.
  • Technology Approaches: Evaluates automated image segmentation, structured reporting, triage functionality, adoption of generative AI for documentation, and integration of large language model-driven features into platform offerings.

Key Takeaways

  • AI for cardiovascular imaging is evolving beyond standalone algorithms, with a shift towards integrated, end-to-end platforms that enhance workflow integration and corporate governance.
  • Senior stakeholders now look for solutions delivering clinical value aligned with real-world operations, favoring tools that integrate seamlessly into existing PACS and EHR environments while meeting cybersecurity standards.
  • There is elevated demand for continuous evidence on solution validity—buyers expect providers to demonstrate improved workflow consistency and quality outcomes across various user groups and locations.
  • Generative AI and large language models bolster clinical documentation, supporting more standardized reporting and improved adherence to evidence-based care practices without compromising safety protocols.
  • Cloud-based options support scalability, yet many healthcare organizations retain hybrid approaches to meet stringent data residency and low-latency requirements. Increasingly, managed service models help reduce the operational effort needed for deployment and ongoing maintenance.
  • Adoption varies considerably by region, reflecting diverse local regulations and healthcare infrastructures. Vendors must tailor their offerings and compliance approaches to successfully address market fragmentation and heterogeneous readiness levels.

Tariff Impact on Deployment and Cost Structure

Tariff adjustments in the United States from 2025 have reshaped procurement strategies by raising the cost of hardware essential to AI imaging, especially GPU servers, networking, and storage. Although software is often exempt, its reliance on underlying hardware means buyers are carefully evaluating total cost of ownership. This dynamic has fuelled greater consideration of cloud and subscription-based AI models, promoting hardware-agnostic solutions and flexible deployments. In response to increased volatility, provider organizations are scrutinizing their vendor risk and exploring diversified supply chains to ensure reliable service continuity.

Methodology & Data Sources

This research combines secondary review of regulatory materials, commercial literature, and published clinical studies with direct interviews from operational, clinical, IT, and industry leaders. Triangulation across these sources ensures robust mapping of product features, market trends, and adoption barriers. All analysis undergoes structured quality control for terminology and assumption validation, facilitating accurate strategic planning.

Why This Report Matters

  • Empowers procurement and strategy teams to benchmark vendors objectively on workflow integration, enterprise governance, and clinical performance, supporting better investment outcomes.
  • Guides technology leaders in identifying essential deployment, compliance, and validation factors crucial for enterprise-scale AI adoption.
  • Highlights unique regional market constraints and growth opportunities, enabling customized go-to-market and partnership strategies for global expansion.

Conclusion

AI medical imaging for cardiovascular disease now represents an enterprise capability where success relies on trust, seamless integration, and robust governance. Forward-looking organizations that focus on measurable workflow improvements and flexible deployments are best placed to achieve lasting clinical impact as technology and regulatory conditions progress.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. AI Medical Imaging Software for Cardiovascular Disease Market, by Technology
8.1. Computer Vision
8.2. Deep Learning
8.2.1. Convolutional Neural Network
8.2.2. Generative Adversarial Network
8.2.3. Recurrent Neural Network
8.3. Machine Learning
8.3.1. Decision Tree
8.3.2. Random Forest
8.3.3. Support Vector Machine
8.4. Natural Language Processing
9. AI Medical Imaging Software for Cardiovascular Disease Market, by Imaging Modality
9.1. CT
9.1.1. CT Angiography
9.1.2. CT Perfusion
9.2. Echocardiography
9.2.1. 2D Echo
9.2.2. 3D Echo
9.2.3. Doppler Echo
9.3. Fluoroscopy
9.4. MRI
9.4.1. Cardiac MRI
9.4.2. MR Angiography
9.5. X Ray
10. AI Medical Imaging Software for Cardiovascular Disease Market, by Deployment Mode
10.1. Cloud
10.1.1. Hybrid Cloud
10.1.2. Private Cloud
10.1.3. Public Cloud
10.2. On Premise
10.2.1. Appliance Based
10.2.2. Server Based
11. AI Medical Imaging Software for Cardiovascular Disease Market, by Application
11.1. Arrhythmia
11.2. Congenital Heart Disease
11.3. Coronary Artery Disease
11.4. Heart Failure
11.5. Valvular Disease
12. AI Medical Imaging Software for Cardiovascular Disease Market, by End User
12.1. Ambulatory Clinics
12.2. Diagnostic Centers
12.3. Hospitals
12.4. Research Institutes
13. AI Medical Imaging Software for Cardiovascular Disease Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. AI Medical Imaging Software for Cardiovascular Disease Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. AI Medical Imaging Software for Cardiovascular Disease Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States AI Medical Imaging Software for Cardiovascular Disease Market
17. China AI Medical Imaging Software for Cardiovascular Disease Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Aidoc Medical Ltd.
18.6. Arterys, Inc.
18.7. Canon Medical Systems Corporation
18.8. CureMetrix Inc.
18.9. Densitas Inc.
18.10. eCure Corp.
18.11. GE HealthCare Technologies Inc.
18.12. HeartFlow, Inc.
18.13. Koninklijke Philips N.V.
18.14. LifeBlood Analytics Ltd.
18.15. Lunit Inc.
18.16. Medis Medical Imaging Systems B.V.
18.17. Quibim SL
18.18. Qure.ai Technologies Pvt. Ltd.
18.19. Siemens Healthineers AG
18.20. Ultromics Ltd.
18.21. VIDA Diagnostics, Inc.
18.22. Viz.ai, Inc.
18.23. Zebra Medical Vision Ltd.
List of Figures
FIGURE 1. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY IMAGING MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY COMPUTER VISION, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY COMPUTER VISION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY COMPUTER VISION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEEP LEARNING, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEEP LEARNING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEEP LEARNING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEEP LEARNING, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CONVOLUTIONAL NEURAL NETWORK, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CONVOLUTIONAL NEURAL NETWORK, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CONVOLUTIONAL NEURAL NETWORK, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY GENERATIVE ADVERSARIAL NETWORK, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY GENERATIVE ADVERSARIAL NETWORK, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY GENERATIVE ADVERSARIAL NETWORK, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY RECURRENT NEURAL NETWORK, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY RECURRENT NEURAL NETWORK, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY RECURRENT NEURAL NETWORK, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MACHINE LEARNING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MACHINE LEARNING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MACHINE LEARNING, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DECISION TREE, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DECISION TREE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DECISION TREE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY RANDOM FOREST, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY RANDOM FOREST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY RANDOM FOREST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY SUPPORT VECTOR MACHINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY SUPPORT VECTOR MACHINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY SUPPORT VECTOR MACHINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CT, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CT ANGIOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CT ANGIOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CT ANGIOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CT PERFUSION, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CT PERFUSION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CT PERFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ECHOCARDIOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ECHOCARDIOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ECHOCARDIOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ECHOCARDIOGRAPHY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY 2D ECHO, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY 2D ECHO, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY 2D ECHO, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY 3D ECHO, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY 3D ECHO, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY 3D ECHO, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DOPPLER ECHO, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DOPPLER ECHO, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DOPPLER ECHO, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY FLUOROSCOPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY FLUOROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY FLUOROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MRI, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MRI, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MRI, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CARDIAC MRI, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CARDIAC MRI, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CARDIAC MRI, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MR ANGIOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MR ANGIOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MR ANGIOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY X RAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY X RAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY X RAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CLOUD, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CLOUD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY HYBRID CLOUD, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY HYBRID CLOUD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY HYBRID CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY PRIVATE CLOUD, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY PRIVATE CLOUD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY PRIVATE CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY PUBLIC CLOUD, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY PUBLIC CLOUD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY PUBLIC CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ON PREMISE, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ON PREMISE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ON PREMISE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY APPLIANCE BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY APPLIANCE BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY APPLIANCE BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY SERVER BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY SERVER BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY SERVER BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ARRHYTHMIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ARRHYTHMIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ARRHYTHMIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CONGENITAL HEART DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CONGENITAL HEART DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CONGENITAL HEART DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CORONARY ARTERY DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CORONARY ARTERY DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CORONARY ARTERY DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY HEART FAILURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY HEART FAILURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY VALVULAR DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY VALVULAR DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY VALVULAR DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY AMBULATORY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY AMBULATORY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY AMBULATORY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 129. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 130. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 131. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEEP LEARNING, 2018-2032 (USD MILLION)
TABLE 132. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MACHINE LEARNING, 2018-2032 (USD MILLION)
TABLE 133. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 134. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
TABLE 135. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ECHOCARDIOGRAPHY, 2018-2032 (USD MILLION)
TABLE 136. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
TABLE 137. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 138. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 139. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
TABLE 140. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 141. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 142. NORTH AMERICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 143. NORTH AMERICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 144. NORTH AMERICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEEP LEARNING, 2018-2032 (USD MILLION)
TABLE 145. NORTH AMERICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MACHINE LEARNING, 2018-2032 (USD MILLION)
TABLE 146. NORTH AMERICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 147. NORTH AMERICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
TABLE 148. NORTH AMERICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ECHOCARDIOGRAPHY, 2018-2032 (USD MILLION)
TABLE 149. NORTH AMERICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
TABLE 150. NORTH AMERICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 151. NORTH AMERICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 152. NORTH AMERICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
TABLE 153. NORTH AMERICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 154. NORTH AMERICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 155. LATIN AMERICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. LATIN AMERICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 157. LATIN AMERICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEEP LEARNING, 2018-2032 (USD MILLION)
TABLE 158. LATIN AMERICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MACHINE LEARNING, 2018-2032 (USD MILLION)
TABLE 159. LATIN AMERICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 160. LATIN AMERICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
TABLE 161. LATIN AMERICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ECHOCARDIOGRAPHY, 2018-2032 (USD MILLION)
TABLE 162. LATIN AMERICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
TABLE 163. LATIN AMERICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 164. LATIN AMERICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 165. LATIN AMERICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
TABLE 166. LATIN AMERICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 167. LATIN AMERICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEEP LEARNING, 2018-2032 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MACHINE LEARNING, 2018-2032 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ECHOCARDIOGRAPHY, 2018-2032 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 181. EUROPE AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 182. EUROPE AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 183. EUROPE AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEEP LEARNING, 2018-2032 (USD MILLION)
TABLE 184. EUROPE AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MACHINE LEARNING, 2018-2032 (USD MILLION)
TABLE 185. EUROPE AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 186. EUROPE AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
TABLE 187. EUROPE AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ECHOCARDIOGRAPHY, 2018-2032 (USD MILLION)
TABLE 188. EUROPE AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
TABLE 189. EUROPE AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 190. EUROPE AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 191. EUROPE AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
TABLE 192. EUROPE AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 193. EUROPE AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 194. MIDDLE EAST AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 195. MIDDLE EAST AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 196. MIDDLE EAST AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEEP LEARNING, 2018-2032 (USD MILLION)
TABLE 197. MIDDLE EAST AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MACHINE LEARNING, 2018-2032 (USD MILLION)
TABLE 198. MIDDLE EAST AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 199. MIDDLE EAST AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
TABLE 200. MIDDLE EAST AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ECHOCARDIOGRAPHY, 2018-2032 (USD MILLION)
TABLE 201. MIDDLE EAST AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
TABLE 202. MIDDLE EAST AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 203. MIDDLE EAST AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 204. MIDDLE EAST AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
TABLE 205. MIDDLE EAST AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 206. MIDDLE EAST AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 207. AFRICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 208. AFRICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 209. AFRICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEEP LEARNING, 2018-2032 (USD MILLION)
TABLE 210. AFRICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MACHINE LEARNING, 2018-2032 (USD MILLION)
TABLE 211. AFRICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 212. AFRICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
TABLE 213. AFRICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ECHOCARDIOGRAPHY, 2018-2032 (USD MILLION)
TABLE 214. AFRICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
TABLE 215. AFRICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 216. AFRICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 217. AFRICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
TABLE 218. AFRICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 219. AFRICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 220. ASIA-PACIFIC AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 221. ASIA-PACIFIC AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 222. ASIA-PACIFIC AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEEP LEARNING, 2018-2032 (USD MILLION)
TABLE 223. ASIA-PACIFIC AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MACHINE LEARNING, 2018-2032 (USD MILLION)
TABLE 224. ASIA-PACIFIC AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 225. ASIA-PACIFIC AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
TABLE 226. ASIA-PACIFIC AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ECHOCARDIOGRAPHY, 2018-2032 (USD MILLION)
TABLE 227. ASIA-PACIFIC AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
TABLE 228. ASIA-PACIFIC AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 229. ASIA-PACIFIC AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 230. ASIA-PACIFIC AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
TABLE 231. ASIA-PACIFIC AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 232. ASIA-PACIFIC AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 233. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 234. ASEAN AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 235. ASEAN AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 236. ASEAN AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEEP LEARNING, 2018-2032 (USD MILLION)
TABLE 237. ASEAN AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MACHINE LEARNING, 2018-2032 (USD MILLION)
TABLE 238. ASEAN AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 239. ASEAN AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
TABLE 240. ASEAN AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ECHOCARDIOGRAPHY, 2018-2032 (USD MILLION)
TABLE 241. ASEAN AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
TABLE 242. ASEAN AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 243. ASEAN AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 244. ASEAN AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLIO

Companies Mentioned

The key companies profiled in this AI Medical Imaging Software for Cardiovascular Disease market report include:
  • Aidoc Medical Ltd.
  • Arterys, Inc.
  • Canon Medical Systems Corporation
  • CureMetrix Inc.
  • Densitas Inc.
  • eCure Corp.
  • GE HealthCare Technologies Inc.
  • HeartFlow, Inc.
  • Koninklijke Philips N.V.
  • LifeBlood Analytics Ltd.
  • Lunit Inc.
  • Medis Medical Imaging Systems B.V.
  • Quibim SL
  • Qure.ai Technologies Pvt. Ltd.
  • Siemens Healthineers AG
  • Ultromics Ltd.
  • VIDA Diagnostics, Inc.
  • Viz.ai, Inc.
  • Zebra Medical Vision Ltd.

Table Information

Report AttributeDetails
No. of Pages188
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 2.56 Billion
Forecasted Market Value ( USD ) by 2032 $ 4.94 Billion
Compound Annual Growth Rate10.8%
Regions CoveredGlobal
No. of Companies Mentioned19

Related Topics

Related Reports

AI Medical Imaging Software for Coronary CT Angiography Market - Global Forecast 2026-2032 - Product Image

AI Medical Imaging Software for Coronary CT Angiography Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
AI Medical Imaging Software for Cerebrovascular Diseases Market - Global Forecast 2026-2032 - Product Image

AI Medical Imaging Software for Cerebrovascular Diseases Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Cardiac Imaging Software Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2032 - Product Image

Cardiac Imaging Software Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2032

  • Report
  • 255 Pages
  • Global
From
Medical X-Ray Equipment And Imaging Software - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Medical X-Ray Equipment And Imaging Software - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 127 Pages
  • Global
From
Medical X-Ray Equipment and Imaging Software Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Medical X-Ray Equipment and Imaging Software Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.